CA
NZ
UK
AU
IND
US
Dynex Capital, Inc., a real estate investment trust specializing in mortgage-related investments, filed a prospectus supplement on July 28, 2026, authorizing the sale of approximately 99.3 million shares of common stock under an expanded continuous distribution agreement. The company has engaged ten major financial …
Dynex Capital, Inc., a Virginia-based mortgage real estate investment trust, has executed Amendment No. 10 to its distribution agreement, increasing the total share authorization for at-the-market offerings to 301.3 million shares. The amendment, signed on July 28, 2026, maintains a syndicate of ten major …
Turn Therapeutics Inc., a Delaware-incorporated biopharmaceutical company based in Westlake Village, California, disclosed the release of an updated investor presentation on July 28, 2026. The presentation was furnished to the Securities and Exchange Commission as part of a current report filing. The update provides …
Valmont Industries, Inc. announced that Board Chair Mogens C. Bay has informed the Board of his decision to retire at the end of the company's fiscal year on December 26, 2026. Catherine J. Paglia, currently serving as Vice Chair of the Board and Lead …
Universal Health Services, Inc., a major operator of acute care hospitals and behavioral health facilities across the United States, disclosed its second quarter 2026 financial results on July 27, 2026. The announcement marks a scheduled earnings release tied to the company's ongoing operations in …
ASP Isotopes Inc., a NASDAQ-listed company, disclosed on July 28, 2026, that it will host a Capital Markets Day event in London on September 8, 2026. The announcement was made through a current report filing and accompanying press release. The event, scheduled to begin …
Standard BioTools Inc. has terminated its earnout and royalty obligations with Illumina, Inc. in exchange for approximately $30 million in cash, while simultaneously agreeing to sell its mass cytometry business to Multiplex Bio Inc. for $5 million in debt financing plus potential earnout payments. …
Standard BioTools Inc. disclosed on July 28, 2026, that it has agreed to sell its Mass Cytometry business to Multiplex Bio, a privately held company led by spatial biology veterans. The transaction is expected to close by the end of 2026, substantially concurrent with …
Standard BioTools Inc. announced on July 28, 2026, that it has agreed to divest its mass cytometry business to Multiplex Bio Inc. for $5 million under a purchase agreement signed July 28, 2026. The company simultaneously disclosed that it received approximately $30 million in …
Itron, Inc., the Liberty Lake, Washington-based technology company, disclosed its financial results for the three and six months ended June 30, 2026, in a press release issued on July 28, 2026. The announcement marks the company's periodic financial reporting to investors and the market. …
Please wait processing your request...